Benefits and harms of selective oestrogen receptor modulators (SERMs) to reduce breast cancer risk: A cross-sectional study of methods to communicate risk in primary care

Abstract

Background In Australia, evidence-based guidelines recommend that women consider taking selective oestrogen receptor modulators (SERMs) to reduce their risk of breast cancer. In practice, this requires effective methods for communicating the harms and benefits of taking SERMs so women can make an informed choice. Aim To evaluate how different risk presentations influence women's decisions to consider taking SERMs. Design and setting Cross-sectional, correlational study of Australian women in general practice. Method Three risk communication formats were developed that included graphics, numbers, and text to explain the reduction in breast cancer risk and risk of side effects for women taking..